P-Shot (Priapus Shot) Protocol

HAUS OF ÄSTHETIK

P-SHOT (PRIAPUS SHOT) PROTOCOL

DATE OF IMPLEMENTATION:

1ST APRIL 2025

REVIEW DATE: 1ST APRIL 2026

VERSION NUMBER: 1.0

INTRODUCTION This protocol outlines the safe and clinically appropriate administration of the P-Shot (Priapus Shot) using autologous platelet-rich plasma (PRP) therapy. It is aligned with MHRA, Save Face, JCCP, and HAUS OF ÄSTHETIK’s clinical governance policies including Record Keeping, Consent, Infection Control, and Medicines Management.

Only qualified Doctors, Dentists, or Registered Nurses with specialist PRP and intimate injection training may perform this treatment. A face-to-face medical consultation and informed consent are mandatory before administration.

TREATMENT INDICATION The P-Shot is designed for:

  • Erectile function enhancement in men with mild to moderate ED

  • Increased sensitivity and performance

  • Penile girth and vascularity enhancement

  • Post-surgical recovery and Peyronie’s disease support

  • Improved tissue health through biostimulation

PRODUCT SUITABILITY

  • Autologous PRP using a CE-marked, MHRA-compliant PRP kit

  • Processed under sterile conditions using a validated centrifuge

PRODUCT STORAGE

  • PRP must be used immediately after preparation

  • Must not be stored or reused

  • Kit batch numbers and expiry dates recorded in patient notes

STAFF REQUIREMENTS

  • Medical practitioner trained in intimate PRP injection techniques

  • Must hold valid indemnity and PRP certification

PATIENT ELIGIBILITY Patients must:

  • Be over 18 years old

  • Be medically fit to undergo PRP extraction and injection

  • Present with sexual health or functional concerns treatable by PRP

  • Not be on anticoagulants or have uncontrolled systemic disease

EXCLUSION CRITERIA

  • Under 18 years old

  • Anticoagulant therapy (unless cleared by GP)

  • Active genital infection or dermatological condition

  • Blood-borne virus infection (HIV, HCV, HBV)

  • Haemophilia or platelet dysfunction

  • Psychological expectations not aligned with treatment

PREPARATION

  • Gather sterile PRP kit, butterfly needle, 10ml syringe, spin tubes, alcohol wipes, gloves, sharps bin, sterile gauze

  • Draw 10-20ml blood into citrate-containing tubes

  • Centrifuge as per device protocol to isolate PRP

  • Draw PRP into sterile syringes for immediate injection

PRE-TREATMENT ASSESSMENT

  • Full medical history including sexual and urological health

  • Informed discussion of risks, expectations, and clinical limits

  • Consent signed and retained

  • Baseline photography (if appropriate and with consent)

INJECTION SITES (STANDARD P-SHOT POINTS)

  • Penile shaft (2-3 points per side)

  • Glans penis (1-2 points circumferentially)

INJECTION TECHNIQUE

  • Needle: 30G – 32G; cannula optional for linear retrograde threading

  • Depth: Superficial subdermal for shaft, intradermal for glans

  • Volume: 1-2ml per side (shaft), 0.5-1ml total for glans

  • Use urology-guided anatomical landmarks to avoid vessels

NUMBING & COMFORT

  • Topical anaesthetic (23% lidocaine) under occlusion for 20 minutes

  • Optional penile nerve block with 1% lidocaine without adrenaline

POST-INJECTION MASSAGE

  • Gentle penile massage for even PRP distribution

  • Apply sterile dressing or gauze if needed for minor oozing

RATIONALISATION OF SITES

  • Injection sites selected to maximise PRP diffusion and vascular stimulation

  • Avoidance of key neurovascular bundles to minimise risk

ADDITIONAL TREATMENT AREAS

  • Perineal PRP (optional) for support in Peyronie’s or pelvic tension

SIDE EFFECTS

  • Mild swelling and bruising (60%)

  • Temporary sensitivity changes (40%)

  • Mild oozing at injection sites (30%)

  • Infection (<1%)

  • Pain or fibrosis (rare)

AFTERCARE

  • Avoid sexual activity for 48 hours

  • No hot baths or saunas for 48 hours

  • No alcohol for 24 hours

  • Use mild soap to cleanse the area

  • Wear loose clothing to reduce pressure on area

FOLLOW-UP AND MAINTENANCE

  • Review: 4-6 weeks post-injection

  • Repeat: Every 6-12 months depending on indication

  • Full results typically noted at 8 weeks post-procedure

DOCUMENTATION

  • Record consent, injection volumes, batch codes, centrifuge settings

  • Log adverse events or patient feedback in medical notes

REGULATORY ALIGNMENT This protocol aligns with MHRA, Save Face, JCCP, and CQC standards for intimate injectable treatments. Annual review or immediate update if new guidelines are introduced.

All treatments at HAUS OF ÄSTHETIK are administered by qualified medical practitioners in a regulated clinical setting to ensure safety, discretion, and optimal patient outcomes.